Biotech Hits Record Low on FDA Curveball

At least two analysts have slashed their price targets on ICPT

Digital Content Manager
May 22, 2023 at 10:53 AM
facebook X logo linkedin


Intercept Pharmaceuticals Inc (NASDAQ: ICPT) stock is down 19.3% at $10.95, after a Food and Drug Administration (FDA) panel voted against recommending accelerated approval for its obeticholic acid treatment for non-alcoholic steatohepatitis (NASH) -- a type of fatty liver disease. The panel referenced data suggesting the benefits of the drug did not outweigh the risks.

Two price-target cuts have already rolled in, with Baird cutting its price objective to $18 from $35, while Wainwright took it down to $8 from $14. Analysts are skeptical on ICPT, with eight calling it a tepid "hold" or worse, while the remaining four rated it a "buy" or better. 

Short sellers are in control, with 3.69 million shares sold short, which account for 9.2% of the equity's available float. It would take nearly one week to buy back these bearish bets, at ICPT's average pace of trading. 

The equity's usually quiet options pits are bursting with activity today. So far, 1,310 calls and 1,344 puts have been traded, which is four times the average intraday volume. Most popular by far is the June 10 put.

The security is fresh off its fourth-straight weekly loss, and earlier gapped to an all-time low of $10.75, guided lower by the 20-day moving average. Shares are also pacing for their biggest single-day percentage drop since June 2020, and have shed more than 45% in the last three months.

 

Target Effortless Triple-Digit Gains Every Sunday Evening For Life!

This is your chance to triple your profit potential on Sunday evenings, without spending all your free time watching the market.

On Sundays, as a Weekend Plus subscriber, you’ll get up to 6 trades every Sunday, each targeting gains of 200% or more.

Start targeting gains like the ones our subscribers have seen recently, including:

213.3% GAIN on AutoNation calls
100.0% GAIN on Monster Beverage calls
100.4% GAIN on Walgreens Boots Alliance puts
100.4% GAIN on ON Semiconductor calls
257.7% GAIN on Dell calls

101.0% GAIN on Apollo Global Management calls
103.6% GAIN on JP Morgan  Chase calls
105.3% GAIN on DraftKings calls
101.3% GAIN on Airbnb calls
203.0% GAIN on Shopify calls
102.0% GAIN on Cboe Global Markets calls
100.9% GAIN on Boeing calls
102.1% GAIN on Microsoft puts
102.3% GAIN on First Solar calls
101.5% GAIN on PulteGroup calls
101.0% GAIN on Apple calls
209.4% GAIN on NXP Semiconductors calls
100.8% GAIN on Uber Technologies calls
100.4% GAIN on Academy Sports and Outdoors puts
102.2% GAIN on Trade Desk calls
100.8% GAIN on DoorDash calls
100.0% GAIN on Camping World Holdings puts
100.0% GAIN on Cboe Global Markets calls
100.2% GAIN on C3.ai calls
238.5% GAIN on Oracle calls

 
 
 


 
 

Rainmaker Ads CGI